Testing an approach to reduce graft-versus-host disease
Graft-versus-host disease is one of the most common complications of stem cell transplantation. Stanford’s Maria Grazia Roncarolo, MD, and her team have launched a clinical trial to test whether T cells can help prevent graft-versus-host disease after stem cell transplantation. This trial is only available at Lucile Packard Children’s Hospital Stanford.
Connect with us:
Download our App: